Cardiac Rhythm Management involves various therapies in administering cardiac arrhythmias, and majorly consists of devices such as Implantable Cardioverter Defibrillators (ICD), implantable pacemakers, and other CRM monitoring devices.
According to TechNavio, the market for Global Cardiac Rhythm Management (CRM) is forecast to reach $12,503.0 million by 2012 from $10,002.9 million in 2008; growing at a CAGR of 5.7 percent over the forecast period.
˜The market for CRM shows a potential growth due to the growing ageing population and increasing number of cardio vascular diseases,™ adds a TechNavio expert. Further, a steady growth of the CRM market is expected over the next few years; owing to favorable drivers and increasing expansion of CRM therapies across different Asian countries (like Japan, India and China).
For further information about this report you can visit https://www.technavio.com/content/global-cardiac-rhythm-management-crm-ma….
The report highlights the scope of the Cardiac Rhythm Management (CRM) industry, along with forecast, trends, drivers and challenges of the market.
Global Cardiac Rhythm Management (CRM) Market 2008-2012
